COMP <GO>
ACCO vs PG // 10Y YIELD & FRED MACRO BETA
Acco Brands Corporation (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: ACCO 4
— PG 8
■ METRIC PARITY
LAST: $4.36 (-0.46%) • MKT CAP: $402.5M
macro-sensitivity
—
LAST: $160.59 (+1.47%) • MKT CAP: $372.21B
macro-sensitivity
0.87
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACCO VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACCO | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.80% | 51.20% | -18.40 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 5.00% | 25.40% | -20.40 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.1x | 16.2x | -3.10 | ACCO | /valuation <GO> |
| Free Cash Flow Yield | 17.07% | 3.77% | +13.30 | ACCO | /fcf-yield <GO> |
| Operating Margin | 6.10% | 24.30% | -18.20 | PG | /operating-margins <GO> |
| Net Profit Margin | 2.70% | 19.00% | -16.30 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | -8.50% | 0.30% | -8.80 | PG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 6.71% | 2.65% | +4.06 | ACCO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.70 | 5.59 | -4.89 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.4 | 60.3 | -12.90 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.0x | 21.7x | -12.70 | ACCO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $402.5M | $372.21B | -$371.81B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACCO REV | PG REV | ACCO GROSS % | PG GROSS % | ACCO FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.52B | $84.28B | 32.8% | 51.2% | $68.7M | $14.04B |
| FY 2024 | $1.67B | $84.04B | 33.3% | 51.4% | $148.2M | $16.52B |
| FY 2023 | $1.83B | $82.01B | — | — | $128.7M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACCO // BETA —
PG // BETA 0.87